China’s 2026 basic health insurance list includes its first CAR-T therapy
Originally reported November 14, 2026. China’s newly announced 2026 national basic medical insurance drug list includes relmacabtagene autoleucel…
Latest stories
-
More than 50 A-share companies disclose share-buyback or stake-increase loan commitments
-
China’s securities regulator calls for research into quantitative trading and share-sale rules
-
Dong Chengfei to Reopen Private Fund Subscriptions After Nearly 18 Months
-
Shanghai exchange disciplines quant-fund trader over silver options transaction
-
United Airlines Moves to Restrict Unauthorized AI Assistants From Its Services
-
China plans to accelerate modern infrastructure development during 15th Five-Year Plan
-
Li Qiang calls for broader pension and social insurance coverage at State Council study session
-
Lilly gains China’s first approval for an oral GLP-1 weight-management drug
Further reading
-
Nvidia shares fall 4.43% after reported leadership shake-up
-
SMIC reports record quarterly sales as demand for AI-supporting chips grows
-
China’s central bank signals broader loan-pricing benchmarks in third-quarter report
-
Strategist Chen Guo sees conditions for an A-share rebound, but expects a bumpy recovery
-
China’s minimum-wage increases: Which workers and businesses are affected?
-
Sotong Development’s controlling shareholder faces post-divorce share dispute
-
China’s Import Expo Highlights Demand from Its Domestic Market
-
JD.com Tests a Free Short-Drama App With Shopping Features Still Unproven
-
Link REIT plans to acquire 50.1% of Singapore’s Eastpoint Mall for S$239.5 million
Read more
-
China’s Finance Ministry Clarifies Offshore Trust Income-Tax Rules
-
China Securities Regulator Outlines Measures to Support Stock Market Stability
-
Ni Runfeng, Who Led Changhong’s Rise in China’s TV Market, Dies at 82
-
Memory Chip Prices Stay Elevated as AI Demand Supports Further Increases, While Consumer-Grade Quotes Remain Negotiable
-
Shanghai Film Says AI Video Revenue Is Under 0.5% After Shares Rise More Than 70% Since November
-
Zhuhai Duty Free Group plans to buy remaining 49% of duty-free company; shares to halt
-
Shengyi Technology Says It Has Received No Notice of End-Customer Order Cancellations
-
A-Share Gains Widen in the Afternoon; ChiNext Closes Up 3.11%
-
Kweichow Moutai Says the Industry Adjustment Is Not Over as iMoutai Shifts Toward Everyday Sales
All articles
-
China’s October Trade Growth Stays Elevated as AI Demand and Energy Prices Rise
-
Former China Communications Construction Chairman Liu Qitao Expelled from the Party
-
Hyperliquid’s H1 2026 Token Economics: Buybacks, Fee Subsidies and Unclaimed Supply
-
Injective’s INJ Economy: How Staking, Buybacks and Tokenized Finance Connect
-
USD.AI’s GPU Lending Model: How Credit Income Funds CHIP Buybacks
-
Zcash Proposal Targets 20-Second Blocks Without Changing Issuance Schedule
-
tBTC network restarts after security pause; $120M Aave reserve stays restricted
-
Elysium’s HYPE Gas and KNTQ Buybacks: How the Hyperliquid L2 Allocates Network Revenue
-
DELTA’s Unrestricted OTC Allocation, Galxe’s Wind-Down and November Token Unlocks